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The lymphangiogenic potency of endothelial growth factors has not been studied to date. This is partially due to the lack of
in vivo lymphangiogenesis assays. We have studied the lymphatics of differentiated avian chorioallantoic membrane (CAM)
using microinjection of Mercox resin, semi- and ultrathin sectioning, immunohistochemical detection of ®bronectin and a-
smooth muscle actin, and in situ hybridization with VEGFR-2 and VEGFR-3 probes. CAM is drained by lymphatic vessels
which are arranged in a regular pattern. Arterioles and arteries are accompanied by a pair of interconnected lymphatics and
form a plexus around bigger arteries. Veins are also associated with lymphatics, particularly larger veins, which are surrounded
by a lymphatic plexus. The lymphatics are characterized by an extremely thin endothelial lining, pores, and the absence of a
basal lamina. Patches of the extracellular matrix can be stained with an antibody against ®bronectin. Lymphatic endothelial
cells of differentiated CAM show ultrastructural features of this cell type. CAM lymphatics do not possess mediae. In contrast,
the lymphatic trunks of the umbilical stalk are invested by a single but discontinuous layer of smooth muscle cells. CAM
lymphatics express VEGFR-2 and VEGFR-3. Both the regular pattern and the typical structure of these lymphatics suggest that
CAM is a suitable site to study the in vivo effects of potential lymphangiogenic factors. We have studied the effects of VEGF
homo- and heterodimers, VEGF/PlGF heterodimers, and PlGF and VEGF-C homodimers on Day 13 CAM. All the growth
factors containing at least one VEGF chain are angiogenic but do not induce lymphangiogenesis. PlGF-1 and PlGF-2 are neither
angiogenic nor lymphangiogenic. VEGF-C is the ®rst lymphangiogenic factor and seems to be highly chemoattractive for
lymphatic endothelial cells. It induces proliferation of lymphatic endothelial cells and development of new lymphatic sinuses
which are directed immediately beneath the chorionic epithelium. Our studies show that VEGF and VEGF-C are speci®c
angiogenic and lymphangiogenic growth factors, respectively. q 1997 Academic Press
INTRODUCTION In a modi®ed version of the CAM assay employing differen-
tiated CAM (Wilting et al., 1991, 1992), the vascular endo-
The development of blood vessels (angiogenesis) has been thelial growth factor (VEGF) (Senger et al., 1983; Connolly
studied extensively during the past years, whereas the de- et al., 1989; Leung et al., 1989) has been shown to be a
velopment of lymphatic vessels (lymphangiogenesis) has highly speci®c angiogenic factor. However, it has rarely
gained relatively little attention, despite the clinical rele- been noted that CAM is drained by a dense network of
vance of lymphangiogenesis. It has been suggested to be lymphatic vessels, although the existence of these vessels
a key process linking lymphological syndromes such has already been described by Budge (1887). CAM therefore
as lymphedema, lymphangiectasia, lymphangioma, and appears to be a suitable site to study the effects of both
lymphangiosarcoma (Witte and Witte, 1986). potential angiogenic and lymphangiogenic factors.
Since the introduction of the chorioallantoic membrane Secreted proteins highly homologous to VEGF have re-
(CAM) assay (Folkman, 1974), this method has often been cently been found. Among these, placenta growth factor
(PlGF) shares 40% identity with VEGF (Maglione et al.,used to study effects of potential angiogenic factors in vivo.
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1991). The function of PlGF is unknown. VEGF-B, which Injection Method
is highly expressed in skeletal muscle and heart, possesses
The lymphatics of 16-day-old chick embryos were perfused with
43% identity with VEGF (Olofsson et al., 1996). Its function glutaraldehyde/formaldehyde ®xative. Two milliliters of Mercox-
has yet to be identi®ed. Furthermore, a growth factor with blue (Norwald, Hamburg, Germany) was mixed with 25 ml of accel-
about 30% identity with VEGF has been named VEGF-C erator and injected into the lymphatics of CAM using ®ne glass
(Joukov et al., 1996). VEGF-C appears to be a potential needles and a micromanipulator.
lymphangiogenic factor, as both VEGF-C receptors, VEGFR-
2 and VEGFR-3 (Joukov et al., 1996), are expressed in lym-
In Situ Hybridizationphatic endothelial cells (Kaipainen et al., 1995; Wilting et
al., 1996, 1997a). In situ hybridization was performed on quail tissue with Quek1/
As a prerequisite for studying the effect of potential VEGFR-2 and Quek2/VEGFR-3 probes (Eichmann et al., 1993,
lymphangiogenic factors, the morphology and pattern of the 1996). The probes were cloned into pcDNA/Amp (Invitrogen, San
Diego). The linearized antisense probes were 3.0 (Quek1) and 1.5lymphatics of normal CAM must be described. We have
kb (Quek2) in length. Specimens were ®xed in Serra's solution,therefore studied the lymphatics of differentiated CAM of
dehydrated, and embedded in paraf®n. Eight-micrometer sectionschick and quail embryos using semi- and ultrathin sec-
were mounted on silan-coated slides, dewaxed, and hybridized attioning, immunohistochemical staining with anti-a-
657C overnight. After washing, the sections were incubated with ansmooth muscle actin and ®bronectin antibodies, in situ hy-
alkaline phosphatase-conjugated sheep anti-digoxigenin antibody
bridization with VEGFR-2 and VEGFR-3 probes, and Mer- (1:4000) at 47C overnight. After washing, nitroblue tetrazolium and
cox injection. We aimed to determine whether VEGF and X-phosphate (Boehringer, Mannheim, Germany) were used as chro-
PlGF homo- and heterodimers and VEGF-C homodimers mogens to reveal a blue signal. The sense probes were used as
affect both blood vascular and lymphatic endothelial cells. controls and did not show a signal (Wilting et al., 1997a).
CAM Assay
MATERIAL AND METHODS
On Day 4 of development, a window was made into the egg shell
of chick eggs. The embryos were checked for normal development
and the eggs sealed with cellotape. They were further incubatedEmbryos
until Day 13. Thermanox coverslips (Nunc, Naperville, IL) were
cut into disks of about 5 mm in diameter. Sterile and salt-freeFertilized eggs of the White Leghorn chick (Gallus gallus) and
growth factors were dissolved in distilled water and about 3.3 mg/the Japanese quail (Coturnix coturnix) were incubated at 37.87C
5 ml was pipetted on the disks. After air-drying, the inverted disksand 80% humidity. Differentiated CAM of 16-day-old chick and
were applied on CAM. After 3 days, the specimens were ®xed in13-day-old quail embryos was studied with the following methods.
3% glutaraldehyde and 2% formaldehyde and rinsed in 0.12 M
sodium cacodylate buffer. They were photographed with a stereo-
microscope (Wild M8) and embedded for semi- and ultrathin sec-
Histology tioning as described above. Controls were performed with carrier
disks alone.
Specimens were ®xed in 3% glutaraldehyde and 2% formalde-
hyde in 0.12 M sodium cacodylate buffer, post®xed with 1% os-
mium solution, immersed with uranyl acetate, and embedded in Growth Factors
Epon resin (Serva, Heidelberg, Germany). Semithin (0.75 mm) and
ultrathin (70 nm) sections were cut with an Ultracut S (Leika, The following human recombinant growth factors were applied
on CAM of 13-day-old chick embryos: VEGF121 (46 experiments),Bensheim, Germany). Ultrathin sections were studied with an EM
10 (Zeiss, Stuttgart, Germany). VEGF165 (29), VEGF121/165 heterodimer (27), PlGF-1 (11), PlGF-2 (14),
VEGF121/PlGF-1 heterodimer (33), and VEGF165/PlGF-2 hetero-
dimer (6). Production of the growth factors in Escherichia coli and
subsequent puri®cation and dimerization have been described re-
Immunohistochemistry cently (BirkenhaÈger et al., 1996). VEGF-C (25) was produced in
insect cells. The endogenous signal sequence for secretion was ex-
Specimens were ®xed in Serra's solution (Serra, 1946), dehy- changed by that of melittin. The N- and C-termini that are proteo-
drated, and embedded in Durcupan resin (Fluka, Buchs, Switzer- lytically processed in vivo to obtain biological activity were omit-
land). Polymerization was performed at 407C. Semithin sections ted (Kukk et al., 1996; Joukov et al., 1996, 1997). All growth factors
(1.5 mm) were collected on silan-coated slides. The resin was dis- were desalted with a PD-10 column (Pharmacia, Uppsala, Sweden)
solved with 20% sodium ethoxide (Merck, Munich, Germany) and and lyophilized.
the sections were rinsed with ethanol and bleached with methanol/
H2O2. Anti-a-smooth muscle actin antibody (Sigma, Deisenhofen,
Germany), diluted 1:5000, was used as ®rst antibody. Peroxidase- Proliferation Studies
conjugated goat anti-mouse IgG (Sigma; 1:200) was used as second
antibody and DAB as chromogen. The B3/D6 ®bronectin antibody Proliferation of blood vascular and lymphatic endothelial cells
was monitored with the BrdU/anti-BrdU method (Gratzner, 1982)(Gardner and Fambrough, 1983) was purchased from the Develop-
mental Studies Hybridoma Bank (Iowa City, IA) and diluted 1:500. after application of VEGF121 and VEGF-C on CAM of 13-day-old
chick embryos. One and two days later, the embryos were incu-Second antibody and DAB staining were described above.
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bated with 100 ml of a 40 mM BrdU solution (Sigma) for 45 min. Receptors of CAM Lymphatics
The specimens were then ®xed with ethanol containing 3% acetic
The expression of VEGFR-2 and VEGFR-3 in differenti-acid. Paraf®n sections were stained as previously described by Wilt-
ated CAM of 13-day-old quail embryos was studied withing et al. (1994).
digoxigenin-labeled RNA probes. In a previous study (Wilt-
ing et al., 1996) it was shown that VEGFR-2 was expressed
in a subpopulation of arterial endothelial cells and in ac-
RESULTS companying vessels, which appeared to be lymphatics. This
result could be con®rmed (Fig. 4a). The vascular endothelial
cells of the intraepithelial capillaries were negative. Fur-Pattern of CAM Lymphatics
thermore, we observed expression of VEGFR-2 in a subpopu-
Mercox injections into the lymphatics were performed in lation of venous endothelial cells. Endothelial cells of the
the region of the allantoic stalk. From here it was possible accompanying lymphatic plexus were also positive (Fig. 4b).
to ®ll both the intraembryonic lymphatics and those of Therefore, in differentiated CAM, a subpopulation of arte-
CAM. A pair of lymphatics was found along the arteries rial and venous endothelial cells and those of the lymphat-
and arterioles of CAM (Fig. 1a). Along the arteries, the pair ics expressed VEGFR-2.
of lymphatics was regularly interconnected by lymphatic In accordance with previous studies (Wilting et al., 1996)
capillaries, and blind-ending extensions were also visible we did not observe expression of VEGFR-3 in endothelial
(Fig. 1b). Furthermore, lymphatics were regularly detected cells of arteries and capillaries (Fig. 4c). Our additional stud-
along veins. A dense network of lymphatics was observed ies on CAM veins showed that these were also negative
surrounding the largest veins (Fig. 1c). Where the arteries (Fig. 4d). However, a signal was detected in endothelial cells
and veins were running in parallel, lymphatics were usually of vessels which were located adjacent to arteries and veins,
located in the angle between them. The CAM lymphatics indicating that these were lymphatics (Figs. 4c and 4d).
were continued to the embryo by collecting ducts along the Therefore, the combination of both VEGFR-2 and VEGFR-
chorioallantoic artery and vein in the allantoic stalk (Fig. 3 was only observed in lymphatic endothelium of differenti-
1d). In the embryo, the lymphatic ducts were connected ated CAM.
with the paired thoracoabdominal trunks (thoracic ducts)
reaching right and left venous angles.
Effects of Endothelial Growth Factors
The angiogenic potential of different VEGF splice formsStructure of CAM Lymphatics
on differentiated CAM has been documented (Wilting et al.,
1992, 1993, 1996). The effects of PlGF homodimers, VEGF/In semithin sections, the lymphatics could be distin-
guished from blood vessels because of their extremely thin PlGF heterodimers, and VEGF-C homodimers have not
been studied in detail, and, except for VEGF121, the potentialendothelial lining (Fig. 2a). Pores were regularly present be-
tween lymphatic endothelial cells. Formation of a media lymphangiogenic potency of growth factors has not been
studied (Wilting et al., 1996).was not observed. This was con®rmed in ultrathin sections
(Fig. 2b). Here it was noted that lymphatic endothelial cells VEGF and PlGF homo- and heterodimers were produced
in E. coli (BirkenhaÈger et al., 1996) and about 3.3 mg of eachpossessed lamellipodia in both luminal and abluminal di-
rections (Figs. 2b and 2c). Focal contacts were observed con- factor was applied on CAM of 13-day-old chick embryos.
The macroscopically visible effects are shown in Fig. 5; thenecting the cells. In the cytoplasm smooth and rough endo-
plasmic reticulum, free ribosomes, Golgi apparatus, and nu- corresponding semithin sections are shown in Fig. 6. In the
controls, no alterations of the vascular pattern were visiblemerous mitochondria were observed (Fig. 2d). Furthermore,
coated pits and vesicles with different inclusions were pres- (Fig. 5a). The capillary plexus was located in the chorionic
epithelium, and all larger conducting and draining vesselsent. Bundles of ®laments were found in some areas (Fig. 2d).
A basal lamina was not present, but patches of extracellular with the accompanying lymphatics were found in the
stroma of CAM (Fig. 6a). VEGF121 induced angiogenesis. For-matrix were visible. These patches could be stained with an
antibody against ®bronectin. Small amounts of ®bronectin mation of new capillaries was seen in the precapillary area
of the vasculature (Fig. 5b). A great number of capillarieswere present throughout the stroma of CAM. Higher
amounts were detected in the media of veins (Fig. 2e). penetrated the stroma of CAM, which normally does not
contain capillaries (Fig. 6b). The lymphatics appeared notThe presence of smooth muscle cells of CAM lymphatics
was also studied in semithin sections using an antibody to be affected. We did not observe sprouting or dilatation
of the lymphatics in the application area (Fig. 6b). The sameagainst a-smooth muscle actin. Smooth muscle cells were
found in all parts of the vascular tree except for the capillar- results were obtained with VEGF165 and the heterodimer
VEGF121/165 . Both forms of the growth factor induced newies. The lymphatics of CAM did not possess a media (Fig.
3a). In contrast, media formation was observed in the region capillaries, whereas the lymphatics were not affected (Figs.
5c, 5d, 6c and 6d). A different result was obtained withof the allantoic stalk. Here the collecting lymphatic ducts
possessed a single but discontinuous layer of smooth mus- PlGF-1 and PlGF-2. Angiogenesis and lymphangiogenesis
were not detected either macroscopically (Figs. 5e and 5f)cle cells (Figs. 3b±3d).
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FIG. 1. Intralymphatic injection of Mercox-blue into a 16-day-old chick embryo. (a) A pair of lymphatics (arrows) is present beside arteries
and arterioles of CAM. (b) Higher magni®cation showing an artery accompanied by a pair of lymphatics (arrows). (c) CAM veins accompanied
by lymphatics (arrow) and surrounded by a lymphatic plexus. (d) Vein leading to the allantoic stalk, surrounded by a lymphatic plexus.
Note formation of lymphatic trunk (arrow). Magni®cation 120.
or in semithin sections (Figs. 6e and 6f). However, the heter- The mitogenic effect of VEGF121 was studied by monitor-
ing the incorporation of BrdU into the DNA. In previousodimers VEGF121/PlGF-1 and VEGF165/PlGF-2 were angio-
genic (Figs. 5g, 5h, and 6g). An effect of the smallest, non- studies we have found that VEGF induces a three- to four-
fold increase of the proliferation rate of endothelial cellsheparin-binding form could be detected even at some dis-
tance from the application area. As before, the lymphatics of CAM (Wilting et al., 1993; Kurz et al., 1995). We now
distinguished between blood vascular and lymphatic endo-remained unaffected (Fig. 6g).
Copyright q 1997 by Academic Press. All rights of reproduction in any form reserved.
AID DB 8639 / 6x29$$$$41 07-07-97 14:28:48 dbal
100 Oh et al.
Copyright q 1997 by Academic Press. All rights of reproduction in any form reserved.
AID DB 8639 / 6x29$$8639 07-07-97 14:28:48 dbal
101VEGF and VEGF-C
FIG. 3. Semithin sections of CAM and the allantoic stalk of 16-day-old chick embryos. (a, c, d) Anti-a-smooth muscle actin staining.
(a) CAM artery (A) invested by smooth muscle cells. The lymphatics (L) do not possess a media. Magni®cation 11100. (b) Section showing
umbilical artery (A), vein (V), and lymphatic trunks (L). Magni®cation 1120. (c) Parallel section showing the presence of a media of
lymphatic trunks. Magni®cation 1120. (d) Higher magni®cation of c. The lymphatic trunk (L) is invested by a single layer of smooth
muscle cells. Magni®cation 1300.
FIG. 2. Structure of CAM lymphatics of 16-day-old chick embryos. (a) Semithin section showing a vein (V) and a lymphatic capillary
(L) with its thin endothelial lining. Magni®cation 11100. (b) Ultrathin section of a lymphatic capillary. There is no investment by any
other cell type. Magni®cation 12500. (c) Lymphatic endothelial cells (L) with numerous lamellinodia. Magni®cation 13500. (d) Higher
magni®cation of c. Lymphatic endothelial cell with Golgi apparatus (G), micro®laments (F), mitochondria (arrow), and several vesicles
(arrowheads). There is no continuous basal lamina. Magni®cation 115,500. (e) Semithin section stained for ®bronectin. There is weak
staining in the stroma and around lymphatic capillaries (L) and strong staining in the media of veins (V). Magni®cation 1300.
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FIG. 4. In situ hybridization on paraf®n sections of CAM of 13-day-old quail embryos. (a) VEGFR-2/Quek1 expression (arrowheads) is
detectable in endothelial cells of arteries (A) and accompanying lymphatics. Magni®cation 1600. (b) VEGFR-2/Quek1 is expressed in
endothelial cells (arrowheads) of veins (V) and accompanying lymphatics. Magni®cation 1400. (c) VEGFR-3/Quek2 expression (arrowheads)
is detectable in endothelial cells of lymphatics. A, artery. Magni®cation 1600. (d) VEGFR-3/Quek2 expression (arrowheads) in a lymphatic
plexus surrounding a vein (V). Magni®cation 1400.
thelial cells. A great number of BrdU-labeled blood vascular formed lymphatics could as well be found as isolated ves-
sels. In semithin sections, the lymphatic nature of theendothelial cells were found after application of VEGF121,
whereas those of the lymphatics were negative (Fig. 7). VEGF-C induced vessels was also visible. They were huge
sinuses with an extremely thin endothelial lining (Fig.VEGF-C was produced in insect cells (Kukk et al., 1996;
Joukov et al., 1996, 1997) and about 3.3 mg was applied 8c). Many folds and endothelial-lined islands were present
within the sinuses, indicative of plexus formation. Ason differentiated CAM. When a 5-ml droplet of VEGF-C-
containing solution was dried on the carrier disk, most there were no obvious signs of sprouting, the new lym-
phatics seemed to grow by intercalation. They were lo-of the protein was found at the border of the droplet.
Therefore, the highest amount of growth factor was ar- cated immediately beneath the chorionic epithelium,
where they are never found in normal CAM (Figs. 8c andranged in a circle, as has also been demonstrated with
other proteins (Wilting et al., 1991). According to the dis- 8d). In the circular region of highest growth factor concen-
tration newly formed vascular capillaries surrounded thetribution of the growth factor, a circular effect of VEGF-
C was visible (Fig. 8a). Within this circle, a weak alter- lymphatics (Fig. 8d). The extremely thin endothelial lin-
ing of the lymphatics and the absence of a basal laminaation of the vascular system was observed. However, this
was not the main effect. By injecting Mercox-blue into were also visible in ultrathin sections (Fig. 8e). Here it
was also observed that there was no formation of a media,the lymphatics it was possible to demonstrate that in the
circular VEGF-C-affected area numerous lymphatics were which could be con®rmed in semithin sections stained
with an antibody against a-smooth muscle actin (notpresent (Fig. 8b). High density of lymphatics was observed
in the whole application site. A huge lymphatic sinus was shown). Proliferation studies revealed a great amount of
BrdU-labeled nuclei of lymphatic endothelial cells afterlocated in the circle of highest growth factor concentra-
tion. Whereas the normal lymphatics of differentiated 1 and 2 days of VEGF-C application (Fig. 8f), the effect
being greater after 1 day.CAM were accompanying blood vessels, the newly
FIG. 5. Effects of endothelial growth factors applied on differentiated CAM of chick embryos. (a) Control. The carrier does not induce
vascular alterations. (b) VEGF121 induces angiogenesis. (c) VEGF165 induces angiogenesis. (d) VEGF121/165 heterodimer induces angiogenesis.
(e) PlGF-1 does not induce angiogenesis. (f) PlGF-2 does not induce angiogenesis. (g) VEGF121/PlGF-1 heterodimer induces angiogenesis.
(h) VEGF165/PlGF-2 heterodimer induces angiogenesis. Magni®cation 112.
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FIG. 6. Semithin sections of growth-factor-treated CAMs corresponding to those in Fig. 5. (a) Control. The capillaries (arrows) are located
in the chorionic epithelium. Arteries, veins, and lymphatics are found in the stroma of CAM. Magni®cation 1450. (b) Effect of VEGF121.
Numerous capillaries are found in the stroma of CAM. Lymphatics seem to be unaffected. Magni®cation 1350. (c) Effect of VEGF165.
Note large amount of blood-®lled capillaries. Lymphatics are not affected. Magni®cation 1450. (d) Effect of VEGF121/165 heterodimer. New
capillaries are present in the stroma of CAM. The lymphatics are not affected. Magni®cation 1450. (e) PlGF-1. Neither an angiogenic nor
a lymphangiogenic effect is present. Magni®cation1450. (f) PlGF-2. There are no signs of angiogenesis or lymphangiogenesis. Magni®cation
1350. (g) VEGF121/PlGF-1 heterodimer. The border of the carrier disk (star) is shown. Due to diffusion, formation of new capillaries in
the stroma of CAM is found even at a distance of 0.6 mm from the application site. Lymphatics are not affected. Magni®cation 1350. A,
artery; L, lymphatics; V, vein.
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and lymphatics (Wilting et al., 1997a), and VEGFR-3 be-
comes restricted to those of lymphatics (Kaipainen et al.,
1995; Wilting et al., 1997a). It has therefore been suggested
that VEGF-C may exert its activities on lymphatics (Kukk
et al., 1996; Wilting et al., 1997b). Lymphatic endothelial
cells have been studied in vitro (Gumkowski et al., 1987;
Witte and Witte, 1987); however, an in vivo assay for poten-
tial lymphangiogenic factors has not previously been de-
scribed.
We have studied the lymphatics of avian CAM. Our re-
sults support the ®ndings of Budge (1887). A pair of lymphat-
ics is present along all arteries and arterioles of CAM. With
increasing size of the arteries, an increasing number of lym-
phatic capillaries interconnects the pair of lymphatics.
Blind-ending extensions are also visible. Veins are also ac-
companied by lymphatics. Again, the number of lymphatic
FIG. 7. Proliferation studies with the BrdU/anti-BrdU method capillaries and the complexity of the lymphatic plexus in-
after application of VEGF121. Numerous BrdU-positive vascular en- crease with increasing size of the veins. Lymph of CAMdothelial cells (black nuclei) are present. Lymphatic (L) endothelial
¯ows into the embryo. Huge lymphatics are located in thecells are negative. A, artery. Original magni®cation 1400.
angle between the umbilical vessels. These lymphatics are
easily visible with a stereomicroscope. They have to be re-
garded as lymphatic trunks since they possess a single layer
of media smooth muscle cells. In avian CAM, lymphaticsDISCUSSION
do not possess a media and they are made up solely of endo-
thelium.Lymphatics of CAM Possess Typical Morphology An extremely thin endothelial lining is one of the charac-
teristics of lymphatic capillaries. Furthermore, their diame-The lymphatics of the chick embryo were ®rst studied
by Albrecht Budge during the seventh and eighth decades ter is usually much bigger than that of blood capillaries.
They also possess pores, and a basal lamina is missing (Cas-of the 19th century. After his death, a survey of these studies
was published by Wilhelm His (Budge, 1887). As early as ley-Smith, 1980; Witte and Witte, 1987; Berens von Rauten-
feld and Drenckhahn, 1994). Therefore, staining with anti-1887, Budge had already noted that the arteries of the CAM
are accompanied by a pair of lymphatics which are intercon- bodies against type IV collagen and laminin is negative
around lymphatic capillaries and in lymphangiomas (Barskynected. The lymphatics are drained into two lymph-hearts
located in the angle between the pelvic and the sacral bones. et al., 1983; Ezaki et al., 1990). The lymphatics of CAM
show all characteristics that have been described for normalFurthermore, they are connected to the paired thoracic
ducts. These are located adjacent to the aorta and lead to lymphatic capillaries: huge diameter, porous and very thin
endothelial lining, and absence of a basal lamina. Fromthe venous angles. Since the original description of CAM
lymphatics by Budge (1887), they have only been brie¯y these characteristics, it is possible to recognize lymphatics
in semithin sections although, in routine paraf®n histology,mentioned in the textbooks by Hamilton (1965) and Ro-
manoff (1960). one cannot be sure to recognize them. However, in CAM,
their regular pattern and location beside arteries and veinsIn contrast to lymphatics, the blood vessels of avian CAM
have gained considerable attention. In the search for angio- is a good help for the recognition of lymphatics, even in
paraf®n sections. Our ®ndings therefore indicate that thegenic factors that may promote tumor vascularization, the
CAM assay has been used to assess effects of growth factors. regular pattern and the normal structure of CAM lymphat-
ics make this organ highly suitable for the study of lymph-The assay was originally performed on Day 10 of develop-
ment (Folkman, 1974). In a modi®ed version, differentiated angiogenic factors.
Our studies also show that the lymphatics of CAM ex-CAM of 13-day-old embryos has been shown to respond
selectively to different growth factors (Wilting et al., 1991, press VEGFR-2 and VEGFR-3. This expression pattern has
also been found in intraembryonic sites during late em-1992). VEGF was observed to induce endothelial cell prolif-
eration, upregulation of VEGFR-2, and angiogenesis, with- bryogenesis (Kaipainen et al., 1995; Wilting et al., 1997a).
VEGFR-2 is expressed in blood vascular and lymphatic en-out affecting other cells of CAM (Wilting et al., 1993, 1996;
Kurz et al., 1995). Recently, three more proteins sharing dothelial cells during all stages examined (Wilting et al.,
1997a). This receptor has only been studied in context ofapproximately 30±40% identity with VEGF have been de-
scribed and named VEGF-B, VEGF-C, and PlGF (Maglione et angiogenesis, and not lymphangiogenesis (Millauer et al.,
1993; Shalaby et al., 1995). In early stages of development,al., 1991; Olofsson et al., 1996; Joukov et al., 1996). VEGF-C
binds with high af®nity to VEGFR-2 (¯k-1, KDR) and VEGFR-3 is expressed by all endothelial cells. Later it be-
comes restricted to a subpopulation of endothelial cells,VEGFR-3 (¯t-4) (Joukov et al., 1996). During development
VEGFR-2 is expressed in endothelial cells of blood vessels disappearing ®rst from the arteries. Expression persists only
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in lymphatic endothelial cells, with very few exceptions have to be aware of the fact that the VEGFR-1 has not been
(Kaipainen et al., 1995; Wilting et al., 1997a). The newly cloned to date. Since PlGF is almost exclusively expressed
identi®ed growth factor, VEGF-C, binds with high af®nity in the placenta (Park et al., 1994), it may induce placenta-
to VEGFR-2 and VEGFR-3 (Joukov et al., 1996; Kukk et al., speci®c characteristics of the vasculature.
1996). Our studies show that VEGF-C is a highly speci®c lymph-
angiogenic factor. This is consistent with the expression of
its receptors in lymphatic endothelial cells of differentiated
VEGF and VEGF-C Induce Angiogenesis and tissues (Kaipainen et al., 1995; Wilting et al., 1997a).
Lymphangiogenesis, Respectively Whereas VEGFR-2 is expressed in vascular and lymphatic
endothelial cells throughout development (Wilting et al.,The angiogenic potential of VEGF is well established.
1997a), expression of VEGFR-3 becomes restricted to thoseThis growth factor binds to VEGFR-1 (¯t-1) and VEGFR-2
of lymphatics (Kaipainen et al., 1995; Wilting et al., 1997a).(Terman et al., 1992; Millauer et al., 1993). Targeted muta-
The early lymphatics are therefore indistinguishable fromtions of either the growth factor or its receptors result in
blood vessels, which supports the assumption that they areearly embryonic lethality (Shalaby et al., 1995; Fong et al.,
derived from blood vessels (Sabin, 1909; Clark and Clark,1995; Carmeliet et al., 1996; Ferrara et al., 1996). Both
1920). We suggest that the activity of VEGF-C in embryonicVEGF165 and VEGF121 induce angiogenesis in differentiated
tissues is different from that in differentiated tissues. InCAM (Wilting et al., 1992, 1996). No effect of VEGF121 on
differentiated CAM, VEGF-C induces a very mild angio-the lymphatic system was observed in a previous study
genic response in regions of high growth factor concentra-(Wilting et al., 1996) or in this study. The factor induces
tion. Preliminary studies in our lab indicate that the angio-expression of VEGFR-2 in endothelial cells, but it does not
genic activity of VEGF is enhanced by VEGF-C. However,in¯uence expression of VEGFR-3 (Wilting et al., 1996), to
the main effect of VEGF-C is induction of new lymphatics.which it does not bind. Here, we have compared the activi-
These are located immediately beneath the chorionic epi-ties of different homo- and heterodimeric forms of VEGF.
thelium, which indicates that VEGF-C is a chemoattractantAll forms that contained at least one VEGF chain were capa-
for lymphatic endothelial cells. Whereas VEGF induces de-ble of inducing angiogenesis. Histologically we have never
velopment of vascular capillaries with relatively small di-observed effects in the lymphatics. Since VEGFR-2 is ex-
ameter, VEGF-C induces huge lymphatic sinuses, obviouslypressed in both types of vessels, differences may reside in
due to proliferation and intercalated growth. By morpholog-the expression of VEGFR-1. It is probable that a combined
ical criteria, the lymphatic nature of these vessels canactivation of VEGFR-1 and VEGFR-2 is necessary to induce
clearly be demonstrated. The great amount of lymphatics inangiogenesis. However, differential expression of VEGFR-1
the application area and their unusual location immediatelyin blood vascular and lymphatic endothelium has not been
beneath the chorionic epithelium show that they are newlystudied to date. VEGF/PlGF heterodimers induce angiogen-
formed.esis in differentiated CAM. Such heterodimers have been
No growth factors speci®c for the lymphatic vascular sys-isolated from GS-9L glioma cells (DiSalvo et al., 1995) and
tem have yet been described. VEGF regulates vascular per-have been found in conditioned media of human tumor cell
meability and angiogenesis, but it does not promote lymph-lines (Cao et al., 1996). Therefore, in some tumors this het-
angiogenesis. Overexpression of VEGF-C, a ligand oferodimer may be an important angiogenic factor.
VEGFR-3 and VEGFR-2, in the skin of transgenic mice re-The function of PlGF is much less established. PlGF
sulted in lymphatic, but not vascular, endothelial prolifera-shares 40% amino acid sequence identity with VEGF, and
tion and vessel enlargement (Jeltsch et al., 1997). Thus,it binds only to VEGFR-1 (Maglione et al., 1991; Hauser
VEGF-C appears to induce selective hyperplasia of the lym-and Weich, 1993; Park et al., 1994). In differentiated CAM,
phatic vasculature, which is involved in the draining andPlGF-1 and PlGF-2 induce neither angiogenesis nor lymph-
®ltering of interstitial ¯uid, in immune function, in in-angiogenesis. Activation of VEGFR-1 does not seem to be
suf®cient to induce angiogenesis. In the avian, however, we ¯ammation, and in tumor metastasis. VEGF-C may have a
FIG. 8. Effect of VEGF-C. (a) VEGF-C does not induce gross alteration of the vascular system of CAM. A circular effect (arrows) is only
visible in the area of highest growth factor concentration. Original magni®cation 112. (b) Intralymphatic injection of Mercox-blue outside
the application area. The solution has ®lled most, but, for technical reasons, not all of the lymphatics in the circular application area.
Note the high density of lymphatics in the application area. A huge lymphatic plexus is located in the circle of highest growth factor
concentration (arrows). Original magni®cation 112. (c, d) Semithin sections of the application area. (c) Newly developed lymphatics (L)
located immediately beneath the chorionic epithelium. Note many intraluminally located endothelial cells (arrows), indicative of plexus
formation. No other cell types are affected. Original magni®cation 1450. (d) In the region of highest VEGF-C concentration, some newly
formed lymphatics (L) are surrounded by vascular capillaries (arrows). Original magni®cation 1450. (e) Ultrathin section of the application
area. Newly formed lymphatics (L) located adjacent to an intrachorionic capillary (C). Note intraluminally projecting lymphatic endothelial
cells (arrows). Original magni®cation 13500. (f) Proliferation studies with the BrdU/anti-BrdU method 1 day after application of VEGF-
C. Lymphatic (L) endothelial cells (arrows) are BrdU positive. V, Vein. Original magni®cation 11000.
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and lethality in embryos lacking a single VEGF gene. Nature 380,role in various disorders involving the lymphatic system
435±439.and it may prove to be useful for therapeutic lymphangio-
Casley-Smith, J. R. (1980). The ®ne structure and functioning ofgenesis.
tissue channels and lymphatics. Lymphology 12, 177±183.In summary, our studies show that differentiated CAM
Clark, E. R., and Clark, E. L. (1920). On the origin and early develop-comprises a regular pattern of lymphatics. The lymphatic
ment of the lymphatic system of the chick. Contr. Embryol. 9,
endothelial cells possess ultrastructural characteristics usu- 447±482.
ally described in this cell type. They express VEGFR-2 and Connolly, D. T., Heuvelman, D., Nelson, R., Olander, J. V., Eppler,
VEGFR-3. CAM is therefore a suitable site to study lymph- B. L., Del®no, J. J., Siegel, N. R., Leimgruber, R. M., and Feder, J.
angiogenic factors. We have shown that VEGF homo- and (1989). Tumor vascular permeability factor stimulates endothe-
heterodimers induce angiogenesis, but not lymphangiogen- lial cell growth and angiogenesis. J. Clin. Invest. 84, 1470±1478.
DiSalvo, J., Bayne, M. L., Conn, G., Kwok, P. W., Trivedi, P. G.,esis; that PlGF is neither angiogenic nor lymphangiogenic;
Sonderman, D. D., Palisi, T. M., Sullivan, K. A., and Thomas,and that VEGF-C is the ®rst member of the VEGF family
K. A. (1995). Puri®cation and characterization of a naturally oc-that speci®cally induces lymphangiogenesis.
curing vascular endothelial growth factor:placenta growth factor
heterodimer. J. Biol. Chem. 270, 7717±7723.
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